0001628280-24-001190.txt : 20240111 0001628280-24-001190.hdr.sgml : 20240111 20240111170609 ACCESSION NUMBER: 0001628280-24-001190 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Odence-Ford Marion CENTRAL INDEX KEY: 0001845002 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38543 FILM NUMBER: 24529892 MAIL ADDRESS: STREET 1: 400 WATER STREET STREET 2: SUITE 200 CITY: ROCHESTER STATE: MI ZIP: 48307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OptimizeRx Corp CENTRAL INDEX KEY: 0001448431 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 261265381 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 260 CHARLES STREET STREET 2: SUITE 302 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 248-651-6558 MAIL ADDRESS: STREET 1: 260 CHARLES STREET STREET 2: SUITE 302 CITY: WALTHAM STATE: MA ZIP: 02453 4 1 wk-form4_1705010757.xml FORM 4 X0508 4 2024-01-09 0 0001448431 OptimizeRx Corp OPRX 0001845002 Odence-Ford Marion C/O OPTIMIZERX CORPORATION 260 CHARLES STREET, SUITE 302 WALTHAM MA 02453 0 1 0 0 General Counsel and CCO 1 Common Stock 2024-01-09 4 S 0 4000 15.1877 D 11114 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.41. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person. /s/ Marion K. Odence-Ford 2024-01-11